How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis

Recently, a large number of experimenters have found that the pathogenesis of Parkinson’s disease may be related to the gut microbiome and proposed the microbiome–gut–brain axis. Studies have shown that Toll-like receptors, especially Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4), are...

Full description

Bibliographic Details
Main Authors: Ziyi Zhang, Zhihui Liu, Ao Lv, Chenhui Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1154626/full
_version_ 1797834745463177216
author Ziyi Zhang
Ziyi Zhang
Zhihui Liu
Ao Lv
Chenhui Fan
author_facet Ziyi Zhang
Ziyi Zhang
Zhihui Liu
Ao Lv
Chenhui Fan
author_sort Ziyi Zhang
collection DOAJ
description Recently, a large number of experimenters have found that the pathogenesis of Parkinson’s disease may be related to the gut microbiome and proposed the microbiome–gut–brain axis. Studies have shown that Toll-like receptors, especially Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4), are key mediators of gut homeostasis. In addition to their established role in innate immunity throughout the body, research is increasingly showing that the Toll-like receptor 2 and Toll-like receptor 4 signaling pathways shape the development and function of the gut and enteric nervous system. Notably, Toll-like receptor 2 and Toll-like receptor 4 are dysregulated in Parkinson’s disease patients and may therefore be identified as the core of early gut dysfunction in Parkinson’s disease. To better understand the contribution of Toll-like receptor 2 and Toll-like receptor 4 dysfunction in the gut to early α-synuclein aggregation, we discussed the structural function of Toll-like receptor 2 and Toll-like receptor 4 and signal transduction of Toll-like receptor 2 and Toll-like receptor 4 in Parkinson’s disease by reviewing clinical, animal models, and in vitro studies. We also present a conceptual model of the pathogenesis of Parkinson’s disease, in which microbial dysbiosis alters the gut barrier as well as the Toll-like receptor 2 and Toll-like receptor 4 signaling pathways, ultimately leading to a positive feedback loop for chronic gut dysfunction, promoting α-synuclein aggregation in the gut and vagus nerve.
first_indexed 2024-04-09T14:42:22Z
format Article
id doaj.art-77f90acd9cf442828b3b97c0a1606729
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-09T14:42:22Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-77f90acd9cf442828b3b97c0a16067292023-05-03T05:21:03ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-05-011410.3389/fimmu.2023.11546261154626How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axisZiyi Zhang0Ziyi Zhang1Zhihui Liu2Ao Lv3Chenhui Fan4Department of Anesthesiology, Baotou Central Hospital, Baotou, ChinaBaotou Clinical Medical College, Inner Mongolia Medical University, Baotou, ChinaDepartment of Anesthesiology, Baotou Central Hospital, Baotou, ChinaThe First Clinical College, Shanxi Medical University, Taiyuan, Shanxi, ChinaSafety Engineering, People’s Public Security University of China, Beijing, ChinaRecently, a large number of experimenters have found that the pathogenesis of Parkinson’s disease may be related to the gut microbiome and proposed the microbiome–gut–brain axis. Studies have shown that Toll-like receptors, especially Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4), are key mediators of gut homeostasis. In addition to their established role in innate immunity throughout the body, research is increasingly showing that the Toll-like receptor 2 and Toll-like receptor 4 signaling pathways shape the development and function of the gut and enteric nervous system. Notably, Toll-like receptor 2 and Toll-like receptor 4 are dysregulated in Parkinson’s disease patients and may therefore be identified as the core of early gut dysfunction in Parkinson’s disease. To better understand the contribution of Toll-like receptor 2 and Toll-like receptor 4 dysfunction in the gut to early α-synuclein aggregation, we discussed the structural function of Toll-like receptor 2 and Toll-like receptor 4 and signal transduction of Toll-like receptor 2 and Toll-like receptor 4 in Parkinson’s disease by reviewing clinical, animal models, and in vitro studies. We also present a conceptual model of the pathogenesis of Parkinson’s disease, in which microbial dysbiosis alters the gut barrier as well as the Toll-like receptor 2 and Toll-like receptor 4 signaling pathways, ultimately leading to a positive feedback loop for chronic gut dysfunction, promoting α-synuclein aggregation in the gut and vagus nerve.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1154626/fullmicrobiome-gut-brain axisParkinson’s diseaseToll-like receptorsimmunityα-synucleinTLR2
spellingShingle Ziyi Zhang
Ziyi Zhang
Zhihui Liu
Ao Lv
Chenhui Fan
How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
Frontiers in Immunology
microbiome-gut-brain axis
Parkinson’s disease
Toll-like receptors
immunity
α-synuclein
TLR2
title How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
title_full How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
title_fullStr How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
title_full_unstemmed How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
title_short How Toll-like receptors influence Parkinson’s disease in the microbiome–gut–brain axis
title_sort how toll like receptors influence parkinson s disease in the microbiome gut brain axis
topic microbiome-gut-brain axis
Parkinson’s disease
Toll-like receptors
immunity
α-synuclein
TLR2
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1154626/full
work_keys_str_mv AT ziyizhang howtolllikereceptorsinfluenceparkinsonsdiseaseinthemicrobiomegutbrainaxis
AT ziyizhang howtolllikereceptorsinfluenceparkinsonsdiseaseinthemicrobiomegutbrainaxis
AT zhihuiliu howtolllikereceptorsinfluenceparkinsonsdiseaseinthemicrobiomegutbrainaxis
AT aolv howtolllikereceptorsinfluenceparkinsonsdiseaseinthemicrobiomegutbrainaxis
AT chenhuifan howtolllikereceptorsinfluenceparkinsonsdiseaseinthemicrobiomegutbrainaxis